Search by Drug Name or NDC

    NDC 27854-0160-24 Flanax 220 mg/1 Details

    Flanax 220 mg/1

    Flanax is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Belmora LLC. The primary component is NAPROXEN SODIUM.

    Product Information

    NDC 27854-0160
    Product ID 27854-160_d1f0d4f4-ac07-4019-ab03-f211b8aa68a4
    Associated GPIs
    GCN Sequence Number 021980
    GCN Sequence Number Description naproxen sodium TABLET 220 MG ORAL
    HIC3 S2B
    HIC3 Description NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
    GCN 47132
    HICL Sequence Number 003726
    HICL Sequence Number Description NAPROXEN SODIUM
    Brand/Generic Generic
    Proprietary Name Flanax
    Proprietary Name Suffix n/a
    Non-Proprietary Name Naproxen Sodium
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 220
    Active Ingredient Units mg/1
    Substance Name NAPROXEN SODIUM
    Labeler Name Belmora LLC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204872
    Listing Certified Through 2024-12-31

    Package

    NDC 27854-0160-24 (27854016024)

    NDC Package Code 27854-160-24
    Billing NDC 27854016024
    Package 1 BOTTLE, PLASTIC in 1 CARTON (27854-160-24) / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
    Marketing Start Date 2018-01-15
    NDC Exclude Flag N
    Pricing Information N/A